Table 1.
Clinical feature | Unstable on DMARD (n = 18) | Stable on DMARD (n = 26) | Stable on combination therapy (n = 20) |
---|---|---|---|
Gender (% female) | 79 | 61 | 85 |
Age (years) | 54.1 | 55.8 | 57.7 |
Race (% white, non-Hispanic) | 67 | 50 | 90 |
Duration of disease (months) | 220 | 200 | 227 |
DMARD use (%) | 75 | 100 | 100 |
Prednisone use (%) | 64 | 75 | 25 |
MTX weekly dose (mg) | 15.5 | 9.95 | 14.5 |
See “Materials and Methods” section for details on patient background and selection.